Dr. Quang A. Le

Western University of Health Sciences, USA

Email: [email protected]

Qualifications

2006 Ph.D., University of Southern California (USC)

1995 B.Sc., University of California at Los Angeles (UCLA)

Publications (selected)

1. Kiener, T., Li, KH., Chiang, E., et al. (2025). Impact of CDK4/6 inhibitors on health-related quality of life outcomes in patients with metastatic breast cancer: A systematic review and meta-analysis. Journal of Managed Care & Specialty Pharmacy, 31(12), 1285–1303.
2. Greene, M., Le, QA., Ozbay, AB., et al. (2025). Completing the colorectal cancer screening process: impact of eliminating cost-sharing for follow-up colonoscopy. Current Medical Research and Opinion, 41(9), 1697–1703.
3. Greene, M., Le, QA., Arroyo, J., et al. (2025). Reaching the Unscreened: Adherence Outcomes From an mt-sDNA CRC Screening Care Gap Program. American Journal of Gastroenterology, 120(10 Suppl 2), S133.
4. Greene, M., Gohil, S., Stieber, B., et al. (2025). Utilization of colorectal cancer screening modalities in the United States (2017-2023): a national multi-payer claims database analysis. Current Medical Research and Opinion, 41(9), 1619–1628.
5. Greene, M., Le, QA., Ozbay, AB., et al. (2025). ADHERENCE TO MULTI-TARGETED STOOL DNA (MT-SDNA) TEST FOR COLORECTAL CANCER REPEAT SCREENING IN AVERAGE-RISK HISPANIC POPULATION. Gastroenterology, 169(1 Suppl S).
6. Greene, M., Stieber, B., Le, QA., et al. (2025). REAL-WORLD ADHERENCE TO FOLLOW-UP COLONOSCOPY AFTER A POSITIVE STOOL-BASED TEST: EXAMINING DIFFERENCES BETWEEN MULTI-TARGET STOOL DNA TESTING VERSUS FECAL IMMUNOCHEMICAL OR FECAL OCCULT BLOOD TESTING BY PAYOR TYPE. Gastroenterology, 169(1 Suppl S).
7. Le, QA., Greene, M., Ozbay, AB., et al. (2025). ADHERENCE TO MULTI-TARGETED STOOL DNA (MT-SDNA) TEST FOR COLORECTAL CANCER REPEAT SCREENING IN AVERAGE-RISK ASIAN AMERICAN POPULATION. Gastroenterology, 169(1 Suppl S), S665.
8. Le, QA., Greene, M., Ozbay, AB., et al. (2025). ADHERENCE TO MULTI-TARGETED STOOL DNA (MT-SDNA) TEST FOR COLORECTAL CANCER REPEAT SCREENING IN AVERAGE-RISK AFRICAN AMERICAN POPULATION. Gastroenterology, 169(1 Suppl S).
9. Le, QA., Li, KH., Ozbay, AB., et al. (2025). PATIENT TEST PREFERENCES FOR COLORECTAL CANCER SCREENING: INSIGHTS FROM A DISCRETE-CHOICE EXPERIMENT. Gastroenterology, 169(1 Suppl 1).
10. Le, QA., Greene, M., Gohil, S., et al. (2025). Adherence to multi-target stool DNA testing for colorectal cancer screening in the United States (vol 40,16,2025). International Journal of Colorectal Disease, 40(1), Article 85.
11. Le, QA., Greene, M., Gohil, S., et al. (2025). Adherence to multi-target stool DNA testing for colorectal cancer screening in the United States. International Journal of Colorectal Disease, 40(1), Article 16.
12. Le, QA., Kiener, T., Johnson, HA., et al. (2025). Adherence to recommended blood-based screening tests for cancer and chronic diseases: A systematic literature review. Preventive Medicine, 191, Article 108213.
13. Ho, A., Kiener, T., Nguyen, QN., & Le, QA. (2024). Effect of statin use on liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease (NAFLD). Journal of Clinical Lipidology, 18(4), e501–e508.
14. Ho, A., Younis, I., & Le, QA. (2022). Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials. Seminars in Arthritis and Rheumatism, 54, Article 151996.
15. Le, QA., & Delevry, D. (2021). Impact of elevated BMI and types of comorbid conditions on health-related quality of life in a nationally representative US sample. Public Health Nutrition, 24(18), 6346–6353.
16. Tanios, M., Nguyen, HM., Le, QA., et al. (2021). Fentanyl- and midazolam-induced coma each influence days of mechanical ventilation and 28-day mortality. Intensive Care Medicine, 47(7), 805–806.
17. Le, QA., Delevry, D., & Anh, H. (2021). Differences between processes of diabetes care and diabetesself-careand their respective perspectives. Journal of Diabetes, 13(2), 175–176.
18. Le, QA., Kang, JH., Lee, S., et al. (2020). Cost-Effectiveness of Treatment Strategies with Biologics in Accordance with Treatment Guidelines for Ankylosing Spondylitis: A Patient-Level Model. Journal of Managed Care & Specialty Pharmacy, 26(10), 1219–1220.
19. Delevry, D., Ho, A., & Le, QA. (2021). Association between processes of diabetes care and health care utilization in patients with diabetes: Evidence from a nationally representative US sample. Journal of Diabetes, 13(1), 78–88.
20. Delevry, D., & Le, QA. (2020). ECONOMIC ANALYSIS OF COMBINATION THERAPY WITH ALPELISIB AND FULVESTRANT FOR TREATMENT OF HORMONE RECEPTOR-POSITIVE (HR plus ) AND HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HER2-) ADVANCED BREAST CANCER. Value in Health, 23(Suppl 1), S32–S33.

Profile Details
https://scholar.google.com/citations?user=c3q7MVQAAAAJ&hl=en
https://www.researchgate.net/profile/Quang-Le-21

WOS ResearcherID: FXT-7503-2022